Processa Pharmaceuticals ...

NASDAQ: PCSA · Real-Time Price · USD
0.33
0.03 (9.78%)
At close: Jun 09, 2025, 3:59 PM

Processa Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.19M 4.71M 6.5M 16.5M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a -2.15M
Other Long-Term Assets
1.2M 5.54K 5.54K 5.54K
Receivables
n/a n/a n/a 70.27K
Inventory
n/a n/a n/a n/a
Other Current Assets
682.29K 926.3K 1.88M n/a
Total Current Assets
1.87M 5.63M 8.39M 18.33M
Property-Plant & Equipment
75.69K 148.61K 227.59K 74.18K
Goodwill & Intangibles
n/a n/a n/a 8.06M
Total Long-Term Assets
1.27M 154.15K 233.12K 8.14M
Total Assets
3.23M 5.79M 8.62M 26.46M
Account Payables
880.88K 311.62K 327.55K 218.91K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
73.02K n/a 78.9K 71.08K
Other Current Liabilities
578.73K 189.04K 110.16K 330.69K
Total Current Liabilities
1.53M 730.58K 998.56K 971.02K
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
487.00 66.91K 150.55K 7.38K
Total Liabilities
1.53M 797.48K 1.15M 978.4K
Total Debt
73.51K 150.55K 229.45K 78.46K
Common Stock
371.00 129.00 1.61K 1.57K
Retained Earnings
-87.22M -75.37M -64.25M -36.82M
Comprehensive Income
n/a -0.00 0.00 0.00
Shareholders Equity
1.7M 4.99M 7.47M 25.49M
Total Investments
n/a n/a n/a -2.15M